DE69528578D1 - Verändertes l2-protein des papillomavirus und damit gestellte viroide - Google Patents

Verändertes l2-protein des papillomavirus und damit gestellte viroide

Info

Publication number
DE69528578D1
DE69528578D1 DE69528578T DE69528578T DE69528578D1 DE 69528578 D1 DE69528578 D1 DE 69528578D1 DE 69528578 T DE69528578 T DE 69528578T DE 69528578 T DE69528578 T DE 69528578T DE 69528578 D1 DE69528578 D1 DE 69528578D1
Authority
DE
Germany
Prior art keywords
protein
viroid
papillomavirus
changed
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69528578T
Other languages
English (en)
Other versions
DE69528578T2 (de
Inventor
Ian Frazer
Jian Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland UQ
CSL Ltd
Original Assignee
University of Queensland UQ
CSL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland UQ, CSL Ltd filed Critical University of Queensland UQ
Publication of DE69528578D1 publication Critical patent/DE69528578D1/de
Application granted granted Critical
Publication of DE69528578T2 publication Critical patent/DE69528578T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69528578T 1994-01-31 1995-01-31 Verändertes l2-protein des papillomavirus und damit gestellte viroide Expired - Lifetime DE69528578T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM3588A AUPM358894A0 (en) 1994-01-31 1994-01-31 Modified papilloma virus l2 protein and vlps formed therefrom
PCT/AU1995/000043 WO1995020659A1 (en) 1994-01-31 1995-01-31 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM

Publications (2)

Publication Number Publication Date
DE69528578D1 true DE69528578D1 (de) 2002-11-21
DE69528578T2 DE69528578T2 (de) 2003-07-17

Family

ID=3778209

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69528578T Expired - Lifetime DE69528578T2 (de) 1994-01-31 1995-01-31 Verändertes l2-protein des papillomavirus und damit gestellte viroide

Country Status (12)

Country Link
US (1) US5993821A (de)
EP (1) EP0750669B1 (de)
JP (1) JP3417948B2 (de)
KR (1) KR100353762B1 (de)
AT (1) ATE226253T1 (de)
AU (1) AUPM358894A0 (de)
DE (1) DE69528578T2 (de)
DK (1) DK0750669T3 (de)
ES (1) ES2187551T3 (de)
NZ (1) NZ279166A (de)
SG (1) SG47362A1 (de)
WO (1) WO1995020659A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
GB9806666D0 (en) * 1998-03-27 1998-05-27 Stanley Margaret Antigen preparation and use
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
AUPR446801A0 (en) 2001-04-18 2001-05-17 University Of Queensland, The Novel compositions and uses therefor
US8288520B2 (en) * 2008-10-27 2012-10-16 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and system
CN107617110A (zh) * 2009-08-26 2018-01-23 西莱克塔生物科技公司 诱导t细胞辅助的组合物
US9376727B2 (en) 2010-05-25 2016-06-28 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically truncated probes
CN113075992B (zh) * 2021-04-13 2022-07-05 浪潮电子信息产业股份有限公司 一种内存上电方法、装置、设备及计算机可读存储介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641081A1 (de) * 1988-12-23 1990-06-29 Medgenix Group
GB9113809D0 (en) * 1991-06-26 1991-08-14 Cancer Res Campaign Tech Papillomavirus l2 protein
KR100240480B1 (ko) * 1991-07-19 2000-03-02 터베이 피터 파필로마 바이러스 백신
ATE494005T1 (de) * 1993-03-09 2011-01-15 Univ Rochester Herstellung von menschlichem papillomaviren hüllprotein und virus-ähnlichen teilchen
GB9306731D0 (en) * 1993-03-31 1993-05-26 Cancer Res Campaign Tech Vaccines

Also Published As

Publication number Publication date
JP3417948B2 (ja) 2003-06-16
ES2187551T3 (es) 2003-06-16
EP0750669A4 (de) 1998-05-27
AUPM358894A0 (en) 1994-02-24
JPH09508273A (ja) 1997-08-26
US5993821A (en) 1999-11-30
DE69528578T2 (de) 2003-07-17
EP0750669A1 (de) 1997-01-02
KR100353762B1 (ko) 2002-12-26
ATE226253T1 (de) 2002-11-15
SG47362A1 (en) 1998-04-17
DK0750669T3 (da) 2003-02-24
WO1995020659A1 (en) 1995-08-03
NZ279166A (en) 1997-11-24
EP0750669B1 (de) 2002-10-16

Similar Documents

Publication Publication Date Title
ATE296111T1 (de) Herstellung von menschlichem papillomavirus hüllprotein und virus-ähnlichen teilchen
ATE202487T1 (de) Mono- oder polyfunktionelle konjugate von polylysine
DE69535018D1 (de) Papillomavirus vakzine
DE59611189D1 (de) Vp-antigene des jc-virus
LU91314I2 (fr) "Combinaison de particules viroides de papillomavirus humain de type 6, 11, 16 et 18 (GARDASIL -GilGARD )"
AP1872A (en) Virus-like particles of human papillomavirus.
ATE376059T1 (de) Assemblierung von wildtyp und chimären influenzavirus-ähnlichen partikeln (vlps)
AU7545801A (en) Chimeric human papillomavirus (hpv) l1 molecules and uses therefor
ATE182362T1 (de) Verfahren zur gewinnung von polyhydroxyalkanoaten mittels windsichtung
DE69528578D1 (de) Verändertes l2-protein des papillomavirus und damit gestellte viroide
ATE263234T1 (de) Veränderte, kleine rna-viren
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
DE69829174D1 (de) Exprimierung eines modifiziertem "foamy virus envelope protein" (hüllenprotein)
MX9707208A (es) Acido desoxiribonucleico que codifica para virus de papiloma humano tipo 18 y uso del mismo.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition